menu
    • menu

    Company profile for Iterum Therapeutics

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Headquartered in Dublin, Ireland, we are a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. We are pursuing a balanced development strategy with multiple opportunities intended to t...
    Headquartered in Dublin, Ireland, we are a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. We are pursuing a balanced development strategy with multiple opportunities intended to treat the organisms responsible for many serious infections, which the Centers for Disease Control (CDC) has determined to be inadequately addressed by current therapies

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Iterum TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 S Wacker Drive Suite 2550 Chicago, IL 60606
    Telephone
    Telephone
    +1 312 778 6070
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.iterumtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/iterum-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Iterum Initiates Wind-Down After Failure To Offload Antibiotic
    Iterum Initiates Wind-Down After Failure To Offload Antibiotic

    31 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/iterum-initiates-wind-down-after-failure-offload-antibiotic-sluggish-sales

    FIERCE PHARMA
    31 Mar 2026
    Share Share
    Iterum Pursues Dual-Track Strategy for First UTI Drug in 25 Years
    Iterum Pursues Dual-Track Strategy for First UTI Drug in 25 Years

    20 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/breaking-down-dual-track-strategy-behind-iterums-launch-first-new-uncomplicated-uti-drug

    FIERCE PHARMA
    20 Aug 2025
    Share Share
    US FDA approves Iterum's treatment for urinary infection
    US FDA approves Iterum's treatment for urinary infection

    26 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-iterums-treatment-urinary-infection-2024-10-25/

    REUTERS
    26 Oct 2024
    Share Share
    FDA Concerns Over Iterum's UTI Drug And Antimicrobial Resistance
    FDA Concerns Over Iterum's UTI Drug And Antimicrobial Resistance

    06 Sep 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fda-concerned-iterums-urinary-tract-infection-drug-could-cause-antimicrobial-resistance

    FIERCE BIOTECH
    06 Sep 2024
    Share Share
    Iterum Announces Positive Topline Results from Phase 3 Trial of Oral Sulopenem
    Iterum Announces Positive Topline Results from Phase 3 Trial of Oral Sulopenem

    30 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iterum-therapeutics-announces-positive-topline-results-from-its-phase-3-reassure-clinical-trial-of-oral-sulopenem-in-uncomplicated-urinary-tract-infections-302047483.html

    PR NEWSWIRE
    30 Jan 2024
    Share Share
    Iterum Therapeutics Reports Employment Inducement Grant
    Iterum Therapeutics Reports Employment Inducement Grant

    11 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/11/2587531/0/en/Iterum-Therapeutics-Reports-Employment-Inducement-Grant.html

    GLOBENEWSWIRE
    11 Jan 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search